PCDHGB7 and cancer: To further assess the cancer-specific cfDNA methylation in various types of cancer and body fluids, the methylation status of TAGMe and PCDHGB7 was analyzed in a prospective multicancer clinical cohort involving 1,158 samples (Figure 1 and Supplemental Figure 1).